• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少动假单胞菌对24种抗菌药物的敏感性

Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents.

作者信息

Smalley D L, Hansen V R, Baselski V S

出版信息

Antimicrob Agents Chemother. 1983 Jan;23(1):161-2. doi: 10.1128/AAC.23.1.161.

DOI:10.1128/AAC.23.1.161
PMID:6600908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC184634/
Abstract

Pseudomonas paucimobilis (group IIK, biotype 1) clinical isolates showed in vitro resistance to ampicillin, carbenicillin, cephalothin, cefoxitin, cefamandole, moxalactam, cefotaxime, cefoperazone, mezlocillin, azlocillin, piperacillin, and ticarcillin. Those agents to which the microbes were shown to be susceptible were tetracycline, chloramphenicol, gentamicin, tobramycin, kanamycin, amikacin, netilmicin, sisomicin, trimethoprim-sulfamethoxazole, ceftazidime, ceftriaxone, and ceftizoxime.

摘要

少动假单胞菌(IIK组,生物型1)临床分离株在体外对氨苄西林、羧苄西林、头孢噻吩、头孢西丁、头孢孟多、莫西沙星、头孢噻肟、头孢哌酮、美洛西林、阿洛西林、哌拉西林和替卡西林耐药。这些微生物显示敏感的药物有四环素、氯霉素、庆大霉素、妥布霉素、卡那霉素、阿米卡星、奈替米星、西索米星、甲氧苄啶-磺胺甲恶唑、头孢他啶、头孢曲松和头孢唑肟。

相似文献

1
Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents.少动假单胞菌对24种抗菌药物的敏感性
Antimicrob Agents Chemother. 1983 Jan;23(1):161-2. doi: 10.1128/AAC.23.1.161.
2
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.新型β-内酰胺类抗生素对囊性纤维化患者铜绿假单胞菌分离株的活性。
Antimicrob Agents Chemother. 1981 Oct;20(4):545-6. doi: 10.1128/AAC.20.4.545.
3
Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.氨曲南、其他β-内酰胺类抗生素及氨基糖苷类抗生素对铜绿假单胞菌的体外活性比较
Chemioterapia. 1984 Aug;3(4):258-61.
4
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.氨基糖苷类药物与β-内酰胺类药物联合用于抗革兰氏阴性菌。体外协同作用及化学相互作用的评估。
Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0.
5
Antibiotic susceptibility of community hospital blood culture isolates of gram-negative bacilli.社区医院革兰氏阴性杆菌血培养分离株的抗生素敏感性
Chemotherapy. 1984;30(1):40-3. doi: 10.1159/000238243.
6
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.铜绿假单胞菌对四种β-内酰胺抗生素(氨苄西林、头孢噻吩、羧苄西林、哌拉西林)、四种氨基糖苷类抗生素(卡那霉素、阿米卡星、庆大霉素、妥布霉素)以及黏菌素的体外敏感性。
Chemotherapy. 1979;25(1):48-53. doi: 10.1159/000237821.
7
Susceptibilities of 45 clinical isolates of Proteus penneri.45株彭氏变形杆菌临床分离株的药敏情况。
Antimicrob Agents Chemother. 1984 Sep;26(3):419-20. doi: 10.1128/AAC.26.3.419.
8
[Resistance of enterobacteria and Pseudomonas to old and new antimicrobial agents].
Bol Med Hosp Infant Mex. 1989 Mar;46(3):163-70.
9
Antibiotic resistance of Acinetobacter calcoaceticus strains isolated from patients treated in intensive care units.从重症监护病房接受治疗的患者中分离出的醋酸钙不动杆菌菌株的抗生素耐药性。
Acta Microbiol Immunol Hung. 1995;42(4):381-7.
10
Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.脲基青霉素与氨基糖苷类药物对铜绿假单胞菌的活性及协同作用。
Infection. 1982;10 Suppl 3:S257-61. doi: 10.1007/BF01640684.

引用本文的文献

1
Steroid and sphingomonas.类固醇和鞘氨醇单胞菌。
Ann Afr Med. 2022 Jul-Sep;21(3):299-300. doi: 10.4103/aam.aam_120_21.
2
A Rare Case of Sphingomonas paucimobilis Spondylodiscitis Managed Surgically.1例经手术治疗的少动鞘氨醇单胞菌性脊椎间盘炎罕见病例
J Orthop Case Rep. 2021 Apr;11(4):91-96. doi: 10.13107/jocr.2021.v11.i04.2166.
3
An evaluation of microbial and chemical contamination sources related to the deterioration of tap water quality in the household water supply system.评估与家庭供水系统中自来水水质恶化有关的微生物和化学污染来源。
Int J Environ Res Public Health. 2013 Sep 6;10(9):4143-60. doi: 10.3390/ijerph10094143.
4
[Septic monarthritis caused by Sphingomonas paucimobilis].少动鞘氨醇单胞菌引起的脓毒性单关节炎
Z Rheumatol. 2013 Oct;72(8):822-6. doi: 10.1007/s00393-013-1237-3.
5
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.曲伐沙星单独及与其他药物联合应用对革兰阴性非发酵菌的比较活性
Antimicrob Agents Chemother. 1997 Jul;41(7):1475-81. doi: 10.1128/AAC.41.7.1475.
6
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.非铜绿假单胞菌革兰氏阴性非发酵菌对环丙沙星、氧氟沙星、左氧氟沙星、D-氧氟沙星、司帕沙星、头孢他啶、哌拉西林、哌拉西林-他唑巴坦、甲氧苄啶-磺胺甲恶唑和亚胺培南的敏感性。
Antimicrob Agents Chemother. 1996 Mar;40(3):772-5. doi: 10.1128/AAC.40.3.772.
7
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
8
Community-acquired bloodstream infection caused by Pseudomonas paucimobilis: case report and review of the literature.少动假单胞菌引起的社区获得性血流感染:病例报告及文献复习
J Clin Microbiol. 1986 Nov;24(5):853-5. doi: 10.1128/jcm.24.5.853-855.1986.
9
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
10
Pseudomonas paucimobilis peritonitis in a patient on CAPD successfully treated with ciprofloxacin and netilmicin.
Eur J Clin Microbiol Infect Dis. 1990 Aug;9(8):630-1. doi: 10.1007/BF01967223.

本文引用的文献

1
Pseudomonas paucimobilis bacteremia.少动假单胞菌血症
J Clin Microbiol. 1981 Jun;13(6):1070-3. doi: 10.1128/jcm.13.6.1070-1073.1981.
2
Preliminary evaluation of the autoSCAN-3, an instrument for automated reading an interpretation of microdilution trays: identification of aerobic gram-negative bacilli.autoSCAN-3的初步评估,一种用于自动读取和解读微量稀释板的仪器:需氧革兰氏阴性杆菌的鉴定
J Clin Microbiol. 1981 Sep;14(3):326-8. doi: 10.1128/jcm.14.3.326-328.1981.